Newswise — MAYWOOD, Il. – Eight internationally known experts in cancer immunology and immunotherapy will speak April 17 at the inaugural Cardinal Bernardin Cancer Center Translational Science Symposium.
Speakers will discuss new approaches for immunotherapy of cancer, basic aspects of tumor immunology, regulation of anti-tumor immunity and the effect on cancer outcomes due to psychological stress on the immune system by environmental interactions.
The program is targeted to basic scientists and physician researchers working in this area. It is sponsored by the Cancer Immunotherapeutics Program of Loyola University Chicago Stritch School of Medicine.
Speakers are:Pramod Srivastava, MD, PhD, University of Connecticut. Dr. Srivastava is known for his work on heat shock proteins and their role in antigen presentation, anti-tumor immunity and autoimmunity.
Jonathan Schneck, MD, PhD, Johns Hopkins University School of Medicine. Dr. Schneck is known for his work on antigen processing and presentation as it relates to in vitro and in vivo priming of anti-tumor immunity.
David Spiegel, MD, Stanford University School of Medicine. Dr. Spiegel's research interests involve stress and health; cognitive control over somatic functions, including cancer progression; response to traumatic stress; and the perception of pain and anxiety.Steven Cole, PhD, David Geffen School of Medicine at UCLA. Dr. Cole's research studies the biological pathways by which social environments influence gene expression by viral, cancer, and immune cell genomes.
Tyler Curiel, MD, University of Texas Health Science Center at San Antonio. Dr. Curiel's laboratory focuses on understanding the immunopathologic basis of human diseases including cancer, infections and autoimmunity.
Shannon Turley, PhD, Harvard Medical School. Dr. Turley's laboratory studies the molecular and cellular aspects of antigen presentation in diseases such as type-1 diabetes, enteritis and pancreatic cancer.
Gregory P Adams, PhD, Temple University School of Medicine. Dr. Adam’s research focuses on optimizing and exploiting engineered antibody fragments to detect and treat solid tumors.Michael Kalos, PhD, University of Pennsylvania School of Medicine. Dr. Kalos studies the biology of T lymphocytes, T cell receptors and chimeric antigen receptors with the focus on how they can be used for treating cancer.
In addition to the oral sessions, there will be a poster session where members of the Loyola Cancer Immunology community will present their work.
For more information, please call 708-327-3207.